James Edward Doyle net worth and biography

James Doyle Biography and Net Worth

Director of Exact Sciences

James E. Doyle is currently Of Counsel at Foley & Lardner LLP, an international law firm, as well as Partner of Doyle & Boyce Strategies, a consultant to several national foundations. Prior to his current positions, Mr. Doyle served two terms as the 44th governor of the state of Wisconsin from 2003 to 2011. Prior to his gubernatorial service, Mr. Doyle served three terms as the attorney general of the state of Wisconsin from 1991 to 2003. In connection with his service as attorney general, Mr. Doyle served as president of the National Association of Attorneys General from 1997 to 1998. Mr. Doyle also previously served as the district attorney of Dane County, Wisconsin and worked in private practice. His extensive public service also includes stints in the Peace Corps as a teacher in Tunisia and as an attorney in a federal legal services office on the Navajo Indian Reservation. Mr. Doyle holds a bachelor's degree from the University of Wisconsin-Madison and earned his Juris Doctorate from Harvard Law School. Mr. Doyle brings to our Board of Directors proven leadership and managerial capabilities acquired through his extensive public and private sector experience. He also provides our Board of Directors with deep knowledge of governmental and legal affairs.

What is James Edward Doyle's net worth?: The estimated net worth of James Edward Doyle is at least $2.75 million as of July 27th, 2023. Mr. Doyle owns 52,110 shares of Exact Sciences stock worth more than $2,746,197 as of November 21st. This net worth evaluation does not reflect any other investments that Mr. Doyle may own. Learn More about James Edward Doyle's net worth.
How do I contact James Edward Doyle?: The corporate mailing address for Mr. Doyle and other Exact Sciences executives is 5505 ENDEAVOR LANE, MADISON WI, 53719. Exact Sciences can also be reached via phone at (608) 284-5700 and via email at [email protected]. Learn More on James Edward Doyle's contact information.
Has James Edward Doyle been buying or selling shares of Exact Sciences?: James Edward Doyle has not been actively trading shares of Exact Sciences over the course of the past ninety days. Most recently, James Edward Doyle sold 2,000 shares of the business's stock in a transaction on Thursday, July 27th. The shares were sold at an average price of $97.42, for a transaction totalling $194,840.00. Following the completion of the sale, the director now directly owns 52,110 shares of the company's stock, valued at $5,076,556.20. Learn More on James Edward Doyle's trading history.
Who are Exact Sciences' active insiders?: Exact Sciences' insider roster includes Brian Baranick (Insider), Sarah Condella (SVP), Kevin Conroy (CEO), D. Coward (Insider), Everett Cunningham (Insider), James Doyle (Director), Jeffrey Elliott (CFO), James Herriott (General Counsel), Torsten Hoof (Insider), Daniel Levangie (Director), Graham Lidgard (Insider), Jacob Orville (Insider), and Katherine Zanotti (Director). Learn More on Exact Sciences' active insiders.
Are insiders buying or selling shares of Exact Sciences?: In the last twelve months, Exact Sciences insiders bought shares 1 times. They purchased a total of 19,500 shares worth more than $1,001,325.00. In the last twelve months, insiders at the medical research company sold shares 36 times. They sold a total of 77,348 shares worth more than $4,737,043.93. The most recent insider tranaction occured on November, 13th when CEO Kevin T Conroy bought 19,500 shares worth more than $1,001,325.00. Insiders at Exact Sciences own 1.4% of the company. Learn More about insider trades at Exact Sciences.
Information on this page was last updated on 11/13/2024.

James Edward Doyle Insider Trading History at Exact Sciences

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/27/2023	Sell	2,000	$97.42	$194,840.00	52,110
6/9/2023	Sell	1,402	$90.51	$126,895.02	54,110
7/31/2020	Sell	2,539	$94.00	$238,666.00	32,459
2/28/2020	Sell	2,000	$77.54	$155,080.00	32,440
3/8/2016	Buy	5,000	$6.43	$32,150.00	21,459

James Edward Doyle Buying and Selling Activity at Exact Sciences

Exact Sciences Company Overview

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Covid-19 testing services. The company's pipeline products focus on enhancing the Cologuard test's performance characteristics and developing blood and other fluid-based tests. It has license agreements with MAYO Foundation for Medical Education and Research, and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.

Today's Range

Now: $52.70

$51.71

$54.17

50 Day Range

MA: $65.32

$49.33

$71.93

2 Week Range

Now: $52.70

$40.62

$79.62

Volume

2,141,771 shs

Average Volume

2,645,736 shs

Market Capitalization

$9.75 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.27

Trump’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

YES, I WANT THE #1 CRYPTO NOW